The Canadian research and development pharmaceutical sector, 2021 / by Christopher Collins, Karine Garneau, Nicole Minnema, and Thomas Wood.: CS11-621/164E-PDF
"This report updates the economic footprint study last conducted on the research and development (R&D) pharmaceutical sector in 2020 with new content for 2021. Innovative Medicines Canada (IMC) paid for the report, and it was produced by the Centre for Innovation, Technology and Enterprise Statistics at Statistics Canada. The pharmaceutical sector’s economic contribution can be seen through various measures, such as the government tax revenue generated by the sector, its employment and job creation, R&D investment, and international trade"--Introduction, page 5.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.938063&sl=0
| Department/Agency |
|
|---|---|
| Title | The Canadian research and development pharmaceutical sector, 2021 / by Christopher Collins, Karine Garneau, Nicole Minnema, and Thomas Wood. |
| Series title |
|
| Publication type | Monograph - View Master Record |
| Language | [English] |
| Other language editions | [French] |
| Format | Digital text |
| Electronic document | |
| Note(s) |
|
| Publishing information |
|
| Author / Contributor |
|
| Description | 1 online resource (31 pages) : maps, graphs. |
| ISBN | 9780660718644 |
| Catalogue number |
|
| Departmental catalogue number | 11‑621‑M |
| Subject terms |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.Page details
- Date modified: